CoreCap Advisors’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-8
Closed -$1.68K – 3334
2026
Q2
$1.68K Buy
+8
New +$1.72K ﹤0.01% 2585
2026
Q1
– Sell
-5
Closed -$1.27K – 3058
2025
Q4
$1.27K Sell
5
-3
-38% -$753 ﹤0.01% 2559
2025
Q3
$1.98K Buy
8
+3
+60% +$718 ﹤0.01% 2378
2025
Q2
$1.2K Sell
5
-3
-38% -$699 ﹤0.01% 2399
2025
Q1
$1.81K Buy
8
+3
+60% +$660 ﹤0.01% 2381
2024
Q4
$1.03K Hold
5
– – ﹤0.01% 2371
2024
Q3
$1.21K Sell
5
-67
-93% -$15.7K ﹤0.01% 2241
2024
Q2
$15.8K Buy
+72
New +$15.6K ﹤0.01% 970
2022
Q1
– Sell
-4
Closed -$1K – 1879
2021
Q4
$1K Buy
+4
New +$914 ﹤0.01% 2243

Other funds holding STE

CoreCap Advisors's STE Position: Q3 2026 in Review

CoreCap Advisors sold out of Steris (STE) in Q3 2026, closing a stake of 8 shares — an estimated $1.68K sold.

CoreCap Advisors first reported a position in STE in Q4 2021 and held it in 9 quarters. The position peaked at $15.8K in Q2 2024. 144 funds tracked by Wall St. Rank hold STE as of Q3 2026.

  • CoreCap Advisors reported no remaining Steris position as of Q3 2026 after selling out during the quarter.
  • CoreCap Advisors sold 8 Steris shares in Q3 2026, an estimated $1.68K.
  • CoreCap Advisors first reported a position in Steris in Q4 2021 and held it in 9 quarters.
  • CoreCap Advisors's Steris position peaked at $15.8K in Q2 2024.
  • 144 funds tracked by Wall St. Rank held Steris as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.